_id
691b15e93c536f8df2318b93
Ticker
IPH.PA
Name
Innate Pharma
Exchange
PA
Address
117, Avenue de Luminy, Marseille, France, 13009
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.innate-pharma.com
Description
Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH45, an antibody drug conjugates (ADC); and IPH67, an undisclosed, multi-specific ANKET. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is based in Marseille, France.
Last Close
1.608
Volume
75817
Current Price
1.53
Change
-0.006
Last Updated
2025-12-31T15:55:55.036Z
Image
https://logo.clearbit.com/www.innate-pharma.com
Ipo Date
2006-11-01T00:00:00.000Z
Market Cap
148224240
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.67
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
4860000
Cost Of Revenue
20520000
Gross Profit
-15660000
Operating Expenses
9767000
Operating Income
-25427000
Interest Expense
229000
Pretax Income
-21344000
Net Income
-21344000
Eps
-0.2455112725665711
Dividends Per Share
-
Shares Outstanding
92179248
Income Tax Expense
-
EBITDA
-25061000
Operating Margin
-523.1893004115227
Total Other Income Expense Net
4083000
Cash
53704000
Short Term Investments
6323000
Receivables
363000
Inventories
-
Total Current Assets
64977999
Property Plant Equipment
4955000
Total Assets
92937000
Payables
4551000
Short Term Debt
8934000
Long Term Debt
-
Total Liabilities
87793000
Equity
5144000
Bs_currency_symbol
EUR
Depreciation
707000
Change In Working Capital
-9959000
Cash From Operations
-31164000
Capital Expenditures
58000
Cash From Investing
6974000
Cash From Financing
10476000
Net Change In Cash
-12692000
Cf_currency_symbol
-
PE
-
PB
25.857994916407467
ROE
-414.9300155520995
ROA
-22.966095311877936
FCF
-31222000
Fcf Percent
-6.424279835390947
Piotroski FScore
0
Health Score
8
Deep Value Investing Score
3
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
1.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
4860000
Quarters > 0 > income Statement > cost Of Revenue
20520000
Quarters > 0 > income Statement > gross Profit
-15660000
Quarters > 0 > income Statement > operating Expenses
9767000
Quarters > 0 > income Statement > operating Income
-25427000
Quarters > 0 > income Statement > interest Expense
229000
Quarters > 0 > income Statement > pretax Income
-21344000
Quarters > 0 > income Statement > net Income
-21344000
Quarters > 0 > income Statement > eps
-0.2455112725665711
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
86936945
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-25061000
Quarters > 0 > income Statement > operating Margin
-523.1893004115227
Quarters > 0 > income Statement > total Other Income Expense Net
4083000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
53704000
Quarters > 0 > balance Sheet > short Term Investments
6323000
Quarters > 0 > balance Sheet > receivables
363000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
64977999
Quarters > 0 > balance Sheet > property Plant Equipment
4955000
Quarters > 0 > balance Sheet > total Assets
92937000
Quarters > 0 > balance Sheet > payables
4551000
Quarters > 0 > balance Sheet > short Term Debt
8934000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
87793000
Quarters > 0 > balance Sheet > equity
5144000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-21344000
Quarters > 0 > cash Flow > depreciation
707000
Quarters > 0 > cash Flow > change In Working Capital
-9959000
Quarters > 0 > cash Flow > cash From Operations
-31164000
Quarters > 0 > cash Flow > capital Expenditures
58000
Quarters > 0 > cash Flow > cash From Investing
6974000
Quarters > 0 > cash Flow > cash From Financing
10476000
Quarters > 0 > cash Flow > net Change In Cash
-12692000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.2455112725665711
Quarters > 0 > ratios > PB
25.857994916407467
Quarters > 0 > ratios > ROE
-414.9300155520995
Quarters > 0 > ratios > ROA
-22.966095311877936
Quarters > 0 > ratios > FCF
-31222000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-6.424279835390947
Quarters > 0 > health Score
8
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
7776000
Quarters > 1 > income Statement > cost Of Revenue
22904000
Quarters > 1 > income Statement > gross Profit
-15128000
Quarters > 1 > income Statement > operating Expenses
32192000
Quarters > 1 > income Statement > operating Income
-25262000
Quarters > 1 > income Statement > interest Expense
3675000
Quarters > 1 > income Statement > pretax Income
-24707000
Quarters > 1 > income Statement > net Income
-24707000
Quarters > 1 > income Statement > eps
-0.30409999834946333
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
81246301
Quarters > 1 > income Statement > income Tax Expense
-3438000
Quarters > 1 > income Statement > EBITDA
-23053000
Quarters > 1 > income Statement > operating Margin
-324.87139917695475
Quarters > 1 > income Statement > total Other Income Expense Net
555000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
66396000
Quarters > 1 > balance Sheet > short Term Investments
14374000
Quarters > 1 > balance Sheet > receivables
4972000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
85742000
Quarters > 1 > balance Sheet > property Plant Equipment
5133000
Quarters > 1 > balance Sheet > total Assets
111059000
Quarters > 1 > balance Sheet > payables
16007000
Quarters > 1 > balance Sheet > short Term Debt
8980000
Quarters > 1 > balance Sheet > long Term Debt
22182000
Quarters > 1 > balance Sheet > total Liabilities
102225000
Quarters > 1 > balance Sheet > equity
8834000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-24707000
Quarters > 1 > cash Flow > depreciation
848000
Quarters > 1 > cash Flow > change In Working Capital
12565000
Quarters > 1 > cash Flow > cash From Operations
-9932000
Quarters > 1 > cash Flow > capital Expenditures
108000
Quarters > 1 > cash Flow > cash From Investing
8268000
Quarters > 1 > cash Flow > cash From Financing
-1681000
Quarters > 1 > cash Flow > net Change In Cash
-3594000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.30409999834946333
Quarters > 1 > ratios > PB
14.071410519583429
Quarters > 1 > ratios > ROE
-279.6807788091465
Quarters > 1 > ratios > ROA
-22.246733718113795
Quarters > 1 > ratios > FCF
-10040000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.2911522633744856
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
12345000
Quarters > 2 > income Statement > cost Of Revenue
29076000
Quarters > 2 > income Statement > gross Profit
-16731000
Quarters > 2 > income Statement > operating Expenses
9582000
Quarters > 2 > income Statement > operating Income
-26313000
Quarters > 2 > income Statement > interest Expense
600000
Quarters > 2 > income Statement > pretax Income
-24764000
Quarters > 2 > income Statement > net Income
-24764000
Quarters > 2 > income Statement > eps
-0.30621088891312187
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
80872369
Quarters > 2 > income Statement > income Tax Expense
-4050000
Quarters > 2 > income Statement > EBITDA
-25563000
Quarters > 2 > income Statement > operating Margin
-213.14702308626977
Quarters > 2 > income Statement > total Other Income Expense Net
1549000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
69990000
Quarters > 2 > balance Sheet > short Term Investments
21809000
Quarters > 2 > balance Sheet > receivables
393000
Quarters > 2 > balance Sheet > inventories
-2958000
Quarters > 2 > balance Sheet > total Current Assets
111594000
Quarters > 2 > balance Sheet > property Plant Equipment
5748000
Quarters > 2 > balance Sheet > total Assets
151497000
Quarters > 2 > balance Sheet > payables
8751000
Quarters > 2 > balance Sheet > short Term Debt
8929000
Quarters > 2 > balance Sheet > long Term Debt
68301000
Quarters > 2 > balance Sheet > total Liabilities
122701000
Quarters > 2 > balance Sheet > equity
28796000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-24764000
Quarters > 2 > cash Flow > depreciation
1146000
Quarters > 2 > cash Flow > change In Working Capital
31310000
Quarters > 2 > cash Flow > cash From Operations
3036000
Quarters > 2 > cash Flow > capital Expenditures
283000
Quarters > 2 > cash Flow > cash From Investing
932000
Quarters > 2 > cash Flow > cash From Financing
-4327000
Quarters > 2 > cash Flow > net Change In Cash
-615000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.30621088891312187
Quarters > 2 > ratios > PB
4.296941400541742
Quarters > 2 > ratios > ROE
-85.9980552854563
Quarters > 2 > ratios > ROA
-16.34619827455329
Quarters > 2 > ratios > FCF
2753000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.22300526528959091
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
6172500
Quarters > 3 > income Statement > cost Of Revenue
14538000
Quarters > 3 > income Statement > gross Profit
-8365500
Quarters > 3 > income Statement > operating Expenses
4791000
Quarters > 3 > income Statement > operating Income
-13156500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-12382000
Quarters > 3 > income Statement > net Income
-12382000
Quarters > 3 > income Statement > eps
-0.15310544445656094
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
80872369
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-12781500
Quarters > 3 > income Statement > operating Margin
-213.14702308626977
Quarters > 3 > income Statement > total Other Income Expense Net
774500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
69990000
Quarters > 3 > balance Sheet > short Term Investments
21809000
Quarters > 3 > balance Sheet > receivables
393000
Quarters > 3 > balance Sheet > inventories
3009000
Quarters > 3 > balance Sheet > total Current Assets
111594000
Quarters > 3 > balance Sheet > property Plant Equipment
5748000
Quarters > 3 > balance Sheet > total Assets
151497000
Quarters > 3 > balance Sheet > payables
8751000
Quarters > 3 > balance Sheet > short Term Debt
8929000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
122701000
Quarters > 3 > balance Sheet > equity
28796000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-12382000
Quarters > 3 > cash Flow > depreciation
571000
Quarters > 3 > cash Flow > change In Working Capital
15655000
Quarters > 3 > cash Flow > cash From Operations
1518000
Quarters > 3 > cash Flow > capital Expenditures
141500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-2163500
Quarters > 3 > cash Flow > net Change In Cash
-308000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.15310544445656094
Quarters > 3 > ratios > PB
4.296941400541742
Quarters > 3 > ratios > ROE
-42.99902764272815
Quarters > 3 > ratios > ROA
-8.173099137276646
Quarters > 3 > ratios > FCF
1376500
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.22300526528959091
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
12622000
Annuals > 0 > income Statement > cost Of Revenue
51980000
Annuals > 0 > income Statement > gross Profit
-31859000
Annuals > 0 > income Statement > operating Expenses
19716000
Annuals > 0 > income Statement > operating Income
-51575000
Annuals > 0 > income Statement > interest Expense
3975000
Annuals > 0 > income Statement > pretax Income
-56959000
Annuals > 0 > income Statement > net Income
-49471000
Annuals > 0 > income Statement > eps
-0.6103612495681785
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
81052000
Annuals > 0 > income Statement > income Tax Expense
-7488000
Annuals > 0 > income Statement > EBITDA
-50990000
Annuals > 0 > income Statement > operating Margin
-408.61194739344
Annuals > 0 > income Statement > total Other Income Expense Net
2104000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
66396000
Annuals > 0 > balance Sheet > short Term Investments
14374000
Annuals > 0 > balance Sheet > receivables
4972000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
85742000
Annuals > 0 > balance Sheet > property Plant Equipment
5133000
Annuals > 0 > balance Sheet > total Assets
111059000
Annuals > 0 > balance Sheet > payables
16007000
Annuals > 0 > balance Sheet > short Term Debt
8980000
Annuals > 0 > balance Sheet > long Term Debt
22182000
Annuals > 0 > balance Sheet > total Liabilities
102225000
Annuals > 0 > balance Sheet > equity
8834000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-49471000
Annuals > 0 > cash Flow > depreciation
1994000
Annuals > 0 > cash Flow > change In Working Capital
39162000
Annuals > 0 > cash Flow > cash From Operations
-6896000
Annuals > 0 > cash Flow > capital Expenditures
391000
Annuals > 0 > cash Flow > cash From Investing
9200000
Annuals > 0 > cash Flow > cash From Financing
-6008000
Annuals > 0 > cash Flow > net Change In Cash
-4209000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.6103612495681785
Annuals > 0 > ratios > PB
14.69835906724021
Annuals > 0 > ratios > ROE
-560.0067919402309
Annuals > 0 > ratios > ROA
-44.544791507216885
Annuals > 0 > ratios > FCF
-7287000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.5773253050229757
Annuals > 0 > health Score
9
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
51901000
Annuals > 1 > income Statement > cost Of Revenue
56022000
Annuals > 1 > income Statement > gross Profit
5619000
Annuals > 1 > income Statement > operating Expenses
18288000
Annuals > 1 > income Statement > operating Income
-12669000
Annuals > 1 > income Statement > interest Expense
640000
Annuals > 1 > income Statement > pretax Income
-7570000
Annuals > 1 > income Statement > net Income
-7570000
Annuals > 1 > income Statement > eps
-0.09409187309474833
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
80453282
Annuals > 1 > income Statement > income Tax Expense
-9729000
Annuals > 1 > income Statement > EBITDA
-1839000
Annuals > 1 > income Statement > operating Margin
-24.409934297990404
Annuals > 1 > income Statement > total Other Income Expense Net
5099000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
70605000
Annuals > 1 > balance Sheet > short Term Investments
21851000
Annuals > 1 > balance Sheet > receivables
46489000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
148012000
Annuals > 1 > balance Sheet > property Plant Equipment
6322000
Annuals > 1 > balance Sheet > total Assets
184193000
Annuals > 1 > balance Sheet > payables
8561000
Annuals > 1 > balance Sheet > short Term Debt
8936000
Annuals > 1 > balance Sheet > long Term Debt
30607000
Annuals > 1 > balance Sheet > total Liabilities
132292000
Annuals > 1 > balance Sheet > equity
51901000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-7570000
Annuals > 1 > cash Flow > depreciation
5091000
Annuals > 1 > cash Flow > change In Working Capital
-32091000
Annuals > 1 > cash Flow > cash From Operations
-32558000
Annuals > 1 > cash Flow > capital Expenditures
2351000
Annuals > 1 > cash Flow > cash From Investing
20631000
Annuals > 1 > cash Flow > cash From Financing
-1966000
Annuals > 1 > cash Flow > net Change In Cash
-13620000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.09409187309474833
Annuals > 1 > ratios > PB
2.483307792990501
Annuals > 1 > ratios > ROE
-14.585460781102483
Annuals > 1 > ratios > ROA
-4.10981959140684
Annuals > 1 > ratios > FCF
-34909000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.6726074642107088
Annuals > 1 > health Score
20
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
49639000
Annuals > 2 > income Statement > cost Of Revenue
51663000
Annuals > 2 > income Statement > gross Profit
6011000
Annuals > 2 > income Statement > operating Expenses
63436000
Annuals > 2 > income Statement > operating Income
-24629000
Annuals > 2 > income Statement > interest Expense
288000
Annuals > 2 > income Statement > pretax Income
-57972000
Annuals > 2 > income Statement > net Income
-58103000
Annuals > 2 > income Statement > eps
-0.7295721615464102
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
79639826
Annuals > 2 > income Statement > income Tax Expense
41131000
Annuals > 2 > income Statement > EBITDA
-61295000
Annuals > 2 > income Statement > operating Margin
-49.61622917464091
Annuals > 2 > income Statement > total Other Income Expense Net
-547000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
84225000
Annuals > 2 > balance Sheet > short Term Investments
17260000
Annuals > 2 > balance Sheet > receivables
31020000
Annuals > 2 > balance Sheet > inventories
-2000
Annuals > 2 > balance Sheet > total Current Assets
139831000
Annuals > 2 > balance Sheet > property Plant Equipment
8542000
Annuals > 2 > balance Sheet > total Assets
207863000
Annuals > 2 > balance Sheet > payables
13656000
Annuals > 2 > balance Sheet > short Term Debt
2102000
Annuals > 2 > balance Sheet > long Term Debt
38929000
Annuals > 2 > balance Sheet > total Liabilities
153712000
Annuals > 2 > balance Sheet > equity
54151000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-58103000
Annuals > 2 > cash Flow > depreciation
45405000
Annuals > 2 > cash Flow > change In Working Capital
-12502000
Annuals > 2 > cash Flow > cash From Operations
-19154000
Annuals > 2 > cash Flow > capital Expenditures
1122000
Annuals > 2 > cash Flow > cash From Investing
1877000
Annuals > 2 > cash Flow > cash From Financing
-1828000
Annuals > 2 > cash Flow > net Change In Cash
-19531000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.7295721615464102
Annuals > 2 > ratios > PB
2.3560599296781226
Annuals > 2 > ratios > ROE
-107.29811083821166
Annuals > 2 > ratios > ROA
-27.95254566709804
Annuals > 2 > ratios > FCF
-20276000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.40846914724309513
Annuals > 2 > health Score
20
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
12112000
Annuals > 3 > income Statement > cost Of Revenue
47004000
Annuals > 3 > income Statement > gross Profit
-34892000
Annuals > 3 > income Statement > operating Expenses
25524000
Annuals > 3 > income Statement > operating Income
-47825000
Annuals > 3 > income Statement > interest Expense
312000
Annuals > 3 > income Statement > pretax Income
-45478000
Annuals > 3 > income Statement > net Income
-52809000
Annuals > 3 > income Statement > eps
-0.6639081708981022
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
79542627
Annuals > 3 > income Statement > income Tax Expense
13658000
Annuals > 3 > income Statement > EBITDA
-43229000
Annuals > 3 > income Statement > operating Margin
-394.8563408190225
Annuals > 3 > income Statement > total Other Income Expense Net
2347000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
103756000
Annuals > 3 > balance Sheet > short Term Investments
16080000
Annuals > 3 > balance Sheet > receivables
18420000
Annuals > 3 > balance Sheet > inventories
-4946000
Annuals > 3 > balance Sheet > total Current Assets
138256000
Annuals > 3 > balance Sheet > property Plant Equipment
10174000
Annuals > 3 > balance Sheet > total Assets
267496000
Annuals > 3 > balance Sheet > payables
28573000
Annuals > 3 > balance Sheet > short Term Debt
30748000
Annuals > 3 > balance Sheet > long Term Debt
46500000
Annuals > 3 > balance Sheet > total Liabilities
160056000
Annuals > 3 > balance Sheet > equity
107440000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-52809000
Annuals > 3 > cash Flow > depreciation
4596000
Annuals > 3 > cash Flow > change In Working Capital
-9884000
Annuals > 3 > cash Flow > cash From Operations
-58457000
Annuals > 3 > cash Flow > capital Expenditures
1330000
Annuals > 3 > cash Flow > cash From Investing
-917000
Annuals > 3 > cash Flow > cash From Financing
26818000
Annuals > 3 > cash Flow > net Change In Cash
-33036000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.6639081708981022
Annuals > 3 > ratios > PB
1.1860320965562174
Annuals > 3 > ratios > ROE
-49.15208488458674
Annuals > 3 > ratios > ROA
-19.741977450130097
Annuals > 3 > ratios > FCF
-59787000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-4.936178996036988
Annuals > 3 > health Score
25
Valuation > metrics > PE
-0.2455112725665711
Valuation > metrics > PB
25.857994916407467
Valuation > final Score
20
Valuation > verdict
761.9% Overvalued
Profitability > metrics > ROE
-414.9300155520995
Profitability > metrics > ROA
-32.848041380898785
Profitability > metrics > Net Margin
-4.391769547325103
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
17.067068429237946
Risk > metrics > Interest Coverage
-111.0349344978166
Risk > final Score
-438
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.818539043381535
Liquidity > metrics > Quick Ratio
4.818539043381535
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
37.03058599458258
Prev Valuations > 2
37.03058599458258
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-21
Prev Risks > 1
-169
Prev Risks > 2
-126
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:10:06.692Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.12
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-13
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.12
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.12
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-17
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.25
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.25
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-30
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.3
Earnings History > 3 > eps Estimate
-0.4
Earnings History > 3 > eps Difference
0.1
Earnings History > 3 > surprise Percent
25
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-27
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.3
Earnings History > 4 > eps Estimate
-0.4
Earnings History > 4 > eps Difference
0.1
Earnings History > 4 > surprise Percent
25
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-13
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-09-04
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
-0.38
Earnings History > 6 > eps Difference
0.38
Earnings History > 6 > surprise Percent
100
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-21
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
-0.41
Earnings History > 8 > eps Difference
0.41
Earnings History > 8 > surprise Percent
100
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-10-19
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-09-14
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
-0.14
Earnings History > 10 > eps Difference
0.14
Earnings History > 10 > surprise Percent
100
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-23
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.73
Earnings History > 12 > eps Estimate
-0.32
Earnings History > 12 > eps Difference
-0.41
Earnings History > 12 > surprise Percent
-128.125
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-14
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-17
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
0.08
Earnings History > 14 > eps Estimate
-0.26
Earnings History > 14 > eps Difference
0.34
Earnings History > 14 > surprise Percent
130.7692
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-03
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.15
Earnings History > 15 > eps Estimate
-0.12
Earnings History > 15 > eps Difference
-0.03
Earnings History > 15 > surprise Percent
-25
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-24
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.27
Earnings History > 16 > eps Estimate
-0.32
Earnings History > 16 > eps Difference
0.05
Earnings History > 16 > surprise Percent
15.625
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-10-26
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-30
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.3
Earnings History > 18 > eps Estimate
-0.23
Earnings History > 18 > eps Difference
-0.07
Earnings History > 18 > surprise Percent
-30.4348
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-04-26
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
0.1
Earnings History > 19 > eps Estimate
0.07
Earnings History > 19 > eps Difference
0.03
Earnings History > 19 > surprise Percent
42.8571
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-18
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
-0.68
Earnings History > 20 > eps Estimate
-0.08
Earnings History > 20 > eps Difference
-0.6
Earnings History > 20 > surprise Percent
-750
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-17
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.08
Earnings History > 21 > eps Estimate
-0.08
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-09-07
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
0.06
Earnings History > 22 > eps Estimate
0.22
Earnings History > 22 > eps Difference
-0.16
Earnings History > 22 > surprise Percent
-72.7273
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-04-23
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
0.1
Earnings History > 23 > eps Estimate
0.07
Earnings History > 23 > eps Difference
0.03
Earnings History > 23 > surprise Percent
42.8571
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-10
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
-0.16
Earnings History > 24 > eps Estimate
-0.08
Earnings History > 24 > eps Difference
-0.08
Earnings History > 24 > surprise Percent
-100
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-13
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
0.04
Earnings History > 25 > eps Estimate
-0.08
Earnings History > 25 > eps Difference
0.12
Earnings History > 25 > surprise Percent
150
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-09-13
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
0.2
Earnings History > 26 > eps Estimate
0.32
Earnings History > 26 > eps Difference
-0.12
Earnings History > 26 > surprise Percent
-37.5
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-15
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
0
Earnings History > 27 > eps Estimate
0.22
Earnings History > 27 > eps Difference
-0.22
Earnings History > 27 > surprise Percent
-100
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-20
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
0.07
Earnings History > 28 > eps Estimate
0.07
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
0
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-15
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
0.07
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
0.07
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-09-14
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
-0.28
Earnings History > 30 > eps Estimate
-0.64
Earnings History > 30 > eps Difference
0.36
Earnings History > 30 > surprise Percent
56.25
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-16
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
EUR
Earnings History > 31 > eps Actual
0
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-08
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
EUR
Earnings History > 32 > eps Actual
-0.46
Earnings History > 32 > eps Estimate
-0.66
Earnings History > 32 > eps Difference
0.2
Earnings History > 32 > surprise Percent
30.303
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-15
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
EUR
Earnings History > 33 > eps Actual
0
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-09-18
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
BeforeMarket
Earnings History > 34 > currency
EUR
Earnings History > 34 > eps Actual
-0.43
Earnings History > 34 > eps Estimate
-0.27
Earnings History > 34 > eps Difference
-0.16
Earnings History > 34 > surprise Percent
-59.2593
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-15
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
BeforeMarket
Earnings History > 35 > currency
EUR
Earnings History > 35 > eps Actual
0
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-07
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
BeforeMarket
Earnings History > 36 > currency
EUR
Earnings History > 36 > eps Actual
0
Earnings History > 36 > eps Estimate
-0.42
Earnings History > 36 > eps Difference
0.42
Earnings History > 36 > surprise Percent
100
Earnings History > 37 > period
2014-12-31
Earnings History > 37 > report Date
2015-02-19
Earnings History > 37 > date
2014-12-31
Earnings History > 37 > before After Market
BeforeMarket
Earnings History > 37 > currency
EUR
Earnings History > 37 > eps Actual
0
Earnings History > 37 > eps Estimate
-0.1
Earnings History > 37 > eps Difference
0.1
Earnings History > 37 > surprise Percent
100
Earnings History > 38 > period
2014-06-30
Earnings History > 38 > report Date
2014-09-17
Earnings History > 38 > date
2014-06-30
Earnings History > 38 > before After Market
AfterMarket
Earnings History > 38 > currency
EUR
Earnings History > 38 > eps Actual
0
Earnings History > 38 > eps Estimate
-0.19
Earnings History > 38 > eps Difference
0.19
Earnings History > 38 > surprise Percent
100
Earnings History > 39 > period
2013-12-31
Earnings History > 39 > report Date
2014-02-11
Earnings History > 39 > date
2013-12-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
EUR
Earnings History > 39 > eps Actual
0
Earnings History > 39 > eps Estimate
-0.06
Earnings History > 39 > eps Difference
0.06
Earnings History > 39 > surprise Percent
100
Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH45, an antibody drug conjugates (ADC); and IPH67, an undisclosed, multi-specific ANKET. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is based in Marseille, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AApple Stock Lags ‘Mag 7’ Peers: Analyst Sees ‘Solid’ iPhone Revenue Amid Risk Of Higher Memory Costs Stocktwits
Read more →Analysts Are Hot on the Foldable iPhone. Should You Buy AAPL Stock Before Apple’s Next Big Product Launch? Barchart.com
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Innate Pharma
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.12
Date
2025-09-30
EPS Actual
-0.12
EPS Estimate
0
EPS Difference
-0.12
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.